Efficacy of Bilateral Ultrasonic Guided Sphenopalatine Ganglion Block in Maxilofacial Cancer Surgeries

Not Applicable

Completed

• Conditions: Maxillofacial Tumors
• Interventions: Other: sphenopalatine block with local anesthetic; Other: sphenopalatine block with saline

• Registration Number: NCT03171090
• Lead Sponsor: Assiut University

Brief Summary

Patients will be randomly allocated according to computer - generated tables to one of two groups, group (A) ultrasonic guided sphenopalatine block using local anasthetic, group (B) ultrasonic guided sphenopalatine block using saline. Before induction anesthesia the following will be assessed, time needed to perform the technique, time till onset of the block, distribution of the block (Opthalmic, Maxillary, Mandibular) by needle brick.Intra and post- operatively the following will be assesse the quality of operative filed every 30 min intra-operatively using a pre- defined average category scale (ACS) (from 0 to 5), End tidal Sevo Flurane concentration will be recorded intra- operatively every 5 minutes, The total amount of Nitroglycerine used to achieve the target MAP and frequency of propranolol usage will be recorded,emergence time, postoperative VAS score and amount of meperdine used for rescue analgesia.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2017-05-25
• Study First Submitted QC: 2017-05-27
• Study First Posted: 2017-05-31
• Study Start: 2017-06-05
• Primary Completion: 2017-10-01
• Study Completion: 2018-03-15
• Status Verified: 2019-10
• Last Update Submitted: 2019-10-27
• Last Update Posted: 2019-10-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Adults patients of ASA physical status I and II, aged 20-70 year who will be scaduled for Maxillo - facial cancer surgeries

Read More

Exclusion Criteria

• patients with disfigurement and disturbed anatomy that will not allow easy access to the sphenopalatine ganglion, bleeding disorders, history of hepatic, renal or cardiopulmonary dysfunction, patients receiving drugs affecting coagulation or cardiovascular active medication are excluded also patients having infection or allergies to local anesthetics

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
sphenopalatine block using saline	sphenopalatine block with local anesthetic	-
sphenopalatine block using local anasthetic	sphenopalatine block with saline	-

Primary Outcome Measures

Name	Time	Method
Post - operative analgesia	24 hours postopeatively	according to VAS measured in the postoperative period

Secondary Outcome Measures

Name	Time	Method
total dose of analgesic consumption	24 hours	total nalufen dose
number of patients required analgesia	24 hours	number of patients required nalufen

Trial Locations

Locations (1)

NCI, Cairo university; 🇪🇬 Cairo, Egypt